APA (7th ed.) Citation

JD, M., D, F., SA, R., VA, D., C, K., SL, M., . . . N, C. (2025). Patient Experience Data (PED) in 2019-2023 US FDA NME Drug Approvals: Analysis and Recommendations. Therapeutic innovation & regulatory science, 59(4), 859. https://doi.org/10.1007/s43441-025-00788-w

Chicago Style (17th ed.) Citation

JD, Martin, Frear D, Roberts SA, Dohnal VA, Kieffer C, Morin SL, Lock I, Balogun A, and Chhina N. "Patient Experience Data (PED) in 2019-2023 US FDA NME Drug Approvals: Analysis and Recommendations." Therapeutic Innovation & Regulatory Science 59, no. 4 (2025): 859. https://doi.org/10.1007/s43441-025-00788-w.

MLA (9th ed.) Citation

JD, Martin, et al. "Patient Experience Data (PED) in 2019-2023 US FDA NME Drug Approvals: Analysis and Recommendations." Therapeutic Innovation & Regulatory Science, vol. 59, no. 4, 2025, p. 859, https://doi.org/10.1007/s43441-025-00788-w.